Invesco Ltd. Glaukos Corp Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Glaukos Corp stock. As of the latest transaction made, Invesco Ltd. holds 1,452,116 shares of GKOS stock, worth $144 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,452,116
Previous 1,458,635
0.45%
Holding current value
$144 Million
Previous $219 Million
34.65%
% of portfolio
0.03%
Previous 0.04%
Shares
26 transactions
Others Institutions Holding GKOS
# of Institutions
364Shares Held
50.2MCall Options Held
260KPut Options Held
776K-
Black Rock Inc. New York, NY8.04MShares$796 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$591 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$227 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$196 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$192 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.71B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...